These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A review of tigecycline. French GL J Chemother; 2008 Oct; 20 Suppl 1():3-11. PubMed ID: 19036669 [TBL] [Abstract][Full Text] [Related]
24. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines]. Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033 [No Abstract] [Full Text] [Related]
25. Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities. Bodmann KF; Heizmann WR; von Eiff C; Petrik C; Löschmann PA; Eckmann C Chemotherapy; 2012; 58(4):282-94. PubMed ID: 23052187 [TBL] [Abstract][Full Text] [Related]
28. Tigecycline: a single antibiotic for polymicrobial infections. Pankey GA; Steele RW Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711 [No Abstract] [Full Text] [Related]
29. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus. Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700 [TBL] [Abstract][Full Text] [Related]
31. Tigecycline-induced acute pancreatitis: case report and literature review. Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093 [TBL] [Abstract][Full Text] [Related]
32. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
34. Tigecycline: place in therapy and important considerations. Garrelts JC; Schroeder T Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574 [No Abstract] [Full Text] [Related]
35. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. Rossitto G; Piano S; Rosi S; Simioni P; Angeli P Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):681-4. PubMed ID: 24667348 [TBL] [Abstract][Full Text] [Related]
36. Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline. Nicolau DP Expert Opin Pharmacother; 2009 May; 10(7):1213-22. PubMed ID: 19405794 [TBL] [Abstract][Full Text] [Related]
37. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii. Housman ST; Hagihara M; Nicolau DP; Kuti JL J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070 [TBL] [Abstract][Full Text] [Related]
38. Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis. Ni W; Han Y; Liu J; Wei C; Zhao J; Cui J; Wang R; Liu Y Medicine (Baltimore); 2016 Mar; 95(11):e3126. PubMed ID: 26986165 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections. Grolman DC Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950 [TBL] [Abstract][Full Text] [Related]